William F. Kiesman - Concepedia

Author

William F. Kiesman

Biogen (United States)ORCID

Also Known As

W. F. KIESMAN, W. F. Kiesman, William F Kiesman, William F. Kiesman, William Kiesman

Publications

951

Citations

H-Index

Concepts

All Affiliations

Biogen (United States)Eli Lilly (United States)Duke University Merck & Co., Inc., Rahway, NJ, USA (United States)Biogen (Switzerland)

About

William F. Kiesman is an author at Biogen (United States) specializing in engineering, catalysis, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Engineering	10	10	462
2	Medicine	9	9	218
3	Natural Sciences	4	4	233
4	Management	2	2	35
5	Business	1	1	17

William F. Kiesman

Publications

774

Citations

H-Index

Page 1

	Year	Citations
Highly Regio- and Enantioselective Catalytic Hydrogenation of Enamides in Conjugated Diene Systems: Synthesis and Application of γ,δ-Unsaturated Amino Acids Mark J. Burk, John G. Allen, William F. Kiesman Journal of the American Chemical Society EngineeringOrganic ChemistryChemistryNatural Product Bulgecinineδ-Unsaturated Amino Acids	1998	123
Soluble Catalysts for Improved Pschorr Cyclizations Frederick W. Wassmundt, William F. Kiesman The Journal of Organic Chemistry EngineeringDatabasesAltmetric Attention ScoreBibliometricsChemistry	1995	57
Synthesis of alkyne derivatives of a novel triazolopyrazine as A2A adenosine receptor antagonists Gang Yao, Serajul Haque, Sha Li, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyMedicineAlkyne DerivativesPharmacological AgentOrganic Chemistry	2004	54
Efficient Catalysis of Hydrodediazoniations in Dimethylformamide Frederick W. Wassmundt, William F. Kiesman The Journal of Organic Chemistry Chemical EngineeringEngineeringChemical AnalysisAltmetric Attention ScoreChemometrics	1995	52
Development of Kilogram-Scale Convergent Liquid-Phase Synthesis of Oligonucleotides Xuan Zhou, William F. Kiesman, Wuming Yan, The Journal of Organic Chemistry EngineeringAnalytical UltracentrifugationOligonucleotide TherapeuticsDna NanotechnologyMedicinal Chemistry	2021	50
Catalytic asymmetric hydrogenation of β-substituted α,β,γ,δ-unsaturated amino acids Mark J. Burk, Karen M. Bedingfield, William F. Kiesman, Tetrahedron Letters EngineeringBiochemistryCatalytic Asymmetric HydrogenationCatalysisHydrogen	1999	44
Potent and Orally Bioavailable 8-Bicyclo[2.2.2]octylxanthines as Adenosine A<sub>1</sub> Receptor Antagonists William F. Kiesman, Jin Zhao, Patrick R. Conlon, Journal of Medicinal Chemistry Acid 29Molecular PharmacologyMedicinal ChemistryBiochemistryFunctional Selectivity	2006	42
Acceleration of Petasis Reactions of Salicylaldehyde Derivatives with Molecular Sieves Xianglin Shi, Dominique Hébrault, Michael Humora, The Journal of Organic Chemistry Chemical EngineeringMolecular SievesEngineeringDerivative (Chemistry)Core Structure	2011	38
Comparison of Three Different A1 Adenosine Receptor Antagonists on Infarct Size and Multiple Cycle Ischemic Preconditioning in Anesthetized Dogs John A. Auchampach, Xiaowei Jin, Jeannine Moore, Journal of Pharmacology and Experimental Therapeutics	2004	37
Catalytic Asymmetric Petasis Reactions of Vinylboronates Xianglin Shi, William F. Kiesman, Anna Levina, The Journal of Organic Chemistry Chemical EngineeringNovel OrganocatalystsEngineeringCross-coupling Reactionå Ms	2013	36

Page 1